childhood infratentorial ependymoma
Showing 1 - 25 of 3,309
CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric
Recruiting
- Central Nervous System Tumor
- +10 more
- SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Ependymoma, Recurrent Childhood, Ependymoma Trial in Denver, Orlando (Granulocyte Macrophage Colony Stimulation Factor)
Active, not recruiting
- Ependymoma, Recurrent Childhood
- Ependymoma
- Granulocyte Macrophage Colony Stimulation Factor
-
Denver, Colorado
- +1 more
Feb 8, 2022
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Recruiting
- Recurrent Childhood Acute Myeloid Leukemia
- +17 more
-
Miami, FloridaNicklaus Children's Hospital
May 13, 2023
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Completed
- Recurrent Childhood Acute Myeloid Leukemia
- +13 more
-
Miami, FloridaNicklaus Children's Hospital
Jan 18, 2023
Stored Tumor Samples in Young Patients With Brain Tumors
Recruiting
- Brain and Central Nervous System Tumors
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 5, 2022
Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- +9 more
- DNA analysis
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 28, 2021
Posterior Fossa Tumor, Medulloblastoma, Childhood Trial in Cairo (Pilates Core Stability Exercises program, Balance Program,
Completed
- Posterior Fossa Tumor
- Medulloblastoma, Childhood
- Pilates Core Stability Exercises program
- +2 more
-
Cairo, EgyptChildren's Cancer Hospital Egypt 57357
Aug 3, 2021
Childhood Ependymoma Trial in Worldwide (16 weeks of VEC + CDDP, VEC + HD-MTX, Chemotherapy + Valproate)
Recruiting
- Childhood Ependymoma
- 16 weeks of VEC + CDDP
- +6 more
-
Graz, Austria
- +39 more
Oct 6, 2021
Childhood Brain Tumor Trial in Germany
Active, not recruiting
- Childhood Brain Tumor
-
Aachen, Germany
- +55 more
Apr 11, 2022
CNS Tumor, Pediatric, Chemo-induced Nausea and Vomiting, Child Solid Tumor Trial in Canada, United States (Real Acupressure
Completed
- Central Nervous System Tumor, Pediatric
- +2 more
- Real Acupressure Band
- Placebo Acupressure Band
-
Long Beach, California
- +24 more
Jul 19, 2021
Anaplastic Ependymoma, Brain Ependymoma, Cellular Ependymoma Trial in Worldwide (radiation, drug, other)
Active, not recruiting
- Anaplastic Ependymoma
- +5 more
- 3-Dimensional Conformal Radiation Therapy
- +7 more
-
Birmingham, Alabama
- +208 more
Mar 7, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
-
Birmingham, Alabama
- +113 more
Jun 28, 2022
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)
Active, not recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- EGFR806-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Jan 18, 2023
Recurrent Childhood Medulloblastoma, Recurrent Ependymoma, Recurrent Medulloblastoma Trial in Houston (Laboratory Biomarker
Completed
- Recurrent Childhood Medulloblastoma
- +2 more
- Laboratory Biomarker Analysis
- Natural Killer Cell Therapy
-
Houston, TexasM D Anderson Cancer Center
Aug 31, 2020
Radioresistance of Ependymomas in Children and Adolescents
Recruiting
- Ependymoma of Brain
- Pediatric Solid Tumor
-
Toulouse, FranceInstitut Claudius Regaud
Dec 8, 2021
Child's Study of Impact of PF Lesion on Motor Skills, Language,
Recruiting
- Medulloblastoma, Childhood
- +3 more
- Functional Magnetic Resonance Imaging (fMRI)
-
Angers, France
- +4 more
Nov 17, 2020
Intracranial Pressure Increase, Posterior Fossa Lesion, Posterior Fossa Hemorrhage Trial in Innsbruck (Multimodal
Recruiting
- Intracranial Pressure Increase
- +2 more
- Multimodal neuromonitoring
-
Innsbruck, Tirol, AustriaMedical University of Innsbruck
Apr 20, 2022
Ependymoma Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))
Terminated
- Ependymoma
- Antineoplaston therapy (Atengenal + Astugenal)
-
Houston, TexasBurzynski Clinic
Feb 18, 2022
Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- Induction Chemotherapy
- +3 more
-
Palo Alto, California
- +5 more
Nov 29, 2022
Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))
Active, not recruiting
- Malignant Glioma
- +2 more
- Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
- Concurrent Optune and RT followed by Optune System alone
-
Los Angeles, California
- +8 more
Jan 17, 2023
CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)
Active, not recruiting
- Central Nervous System Neoplasms
- Medulloblastoma
-
Stanford, California
- +24 more
Sep 28, 2022
Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +31 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +118 more
Jan 27, 2023
Ependymoma, Glioblastoma, Medulloblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR
Recruiting
- Ependymoma
- +3 more
- IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 9, 2022
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)
Recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- HER2-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022